Add like
Add dislike
Add to saved papers

Pretreatment with a β-cyclodextrin - corrosion inhibitor complex stops an initiated corrosion process on zinc.

Metal pretreatment is typically the first step in a reliable corrosion protection system. This work explores the incorporation of complexes between the cyclic oligosaccharide β-cyclodextrin (β-CD) and the molecular organic corrosion inhibitor 2-mercaptobenzothiazole (MBT) into an oxide-based pretreatment layer on metallic zinc. The layers were produced by a precorrosion step in the presence of β-CD. Resulting films have a morphology dominated by spherical particles. X-ray photoelectron spectroscopy (XPS) investigations of the surfaces show the sulfur atoms of MBT to be partially oxidized but mostly intact. Samples pretreated with such a layer where subsequently coated with a model polymer coating, and the delamination of this model coating from an artificial defect was monitored by a scanning Kelvin probe (SKP). SKP results show a slow down of delamination after several hours of the ongoing corrosion process for surfaces pretreated with the complexes. Finally, a lifting of the electrode potential in the defect was observed, with a subsequent complete stop in delamination and repassivation of the defect after ~10 h. The repassivation is attributed to the release of MBT after initiation of the corrosion process. Most likely, the increase of pH, combined with the availability of aqueous solution, facilitates the MBT release after initiation of a corrosion process. Consequently, complexes formed from β-CD and corrosion inhibitors can be effectively incorporated into inorganic pretreatments, and the inhibitor component can be released upon start of the corrosion process.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app